Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences, Medical Solutions Ink Co-Marketing Deal

NEW YORK, March 15 (GenomeWeb News) - Proteome Sciences will market its ProteoShop platform with Medical Solutions' biomarker validation technologies as an integrated package for drug discovery and development.


Financial details were not discussed.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.